Marinomed Biotech AG
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Public
- Established
- 2006-01-01
- Employees
- 52
- Market Cap
- -
- Website
- http://www.marinomed.com
Clinical Trials
10
Active:2
Completed:8
Trial Phases
4 Phases
Phase 1:2
Phase 2:1
Phase 3:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (60.0%)Phase 1
2 (20.0%)Phase 2
1 (10.0%)Phase 3
1 (10.0%)Lubricating Effectiveness of Carragelose Eye Drops in Patients Affected by Mild to Moderate Dry Eye
Not Applicable
Completed
- Conditions
- Dry Eye Syndromes
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 30
- Registration Number
- NCT06262100
- Locations
- 🇪🇸
IOBA,Ocular Surface Research Group, University of Valladolid, Valladolid, Spain
Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients
Not Applicable
Completed
- Conditions
- Covid19
- First Posted Date
- 2021-03-11
- Last Posted Date
- 2022-08-29
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 14
- Registration Number
- NCT04793984
- Locations
- 🇦🇹
Gesundheitsverbund, Klinik Floridsdorf, Vienna, Austria
Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers
Not Applicable
Completed
- Conditions
- COVID-19Severe Acute Respiratory Syndrome (SARS) PneumoniaCorona Virus DiseaseRespiratory Viral InfectionCommon Cold
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 300
- Registration Number
- NCT04681001
- Locations
- 🇦🇹
Gesundheitsverbund, Klinik Favoriten, Vienna, Austria
🇦🇹Gesundheitsverbund Klinik Floridsdorf, Vienna, Austria
Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Common Cold Viruses
Not Applicable
Completed
- Conditions
- Common ColdViral Infection
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2021-01-08
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 29
- Registration Number
- NCT04533906
- Locations
- 🇦🇹
Dr. Friedrich Ehrenreich, Vienna, Austria
Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray.
Not Applicable
Completed
- Conditions
- Allergic RhinitisAllergic Rhinoconjunctivitis
- First Posted Date
- 2020-08-31
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Marinomed Biotech AG
- Target Recruit Count
- 42
- Registration Number
- NCT04532762
- Locations
- 🇦🇹
Vienna Challenge Chamber, Vienna, Austria
- Prev
- 1
- 2
- Next
News
No news found